Glycopyrronium, Formoteroli fumaras dihydricus

Medicinal product name Bevespi Aerosphere
Pharmaceutical form Pressurised inhalation, suspension
Strength 7.2 μg/5.0 μg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/18/1339/001 KZSLN120: 1 × 120 Is available
Legal status Rx Prescription (Pr.)
KZSL Next lowest cost medicine
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code R03AL07 Drugs for obstructive airway diseases

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(69 containers)
Magnum Medical, Tamro, Recipe Plus N120: 1 × 120
(7,2 µg/5 µg)
Aluminium inhaler 72.06 
KZSL*
EU/1/18/1339/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/18/1339/001
Date of authorisation Dec 18, 2018
MA valid until For unlimited time
Marketing authorisation holder, country AstraZeneca AB, Sweden